VV116 or Nirmatrelvir-Ritonavir for Oral Treatment of Covid-19. Reply
N Engl J Med
.
2023 Jun 22;388(25):2396-2397.
doi: 10.1056/NEJMc2305030.
Authors
Zhujun Cao
1
,
Yuan Gao
2
,
Ren Zhao
3
Affiliations
1
Shanghai Jiao Tong University School of Medicine Ruijin Hospital, Shanghai, China.
2
Shanghai Jiao Tong University School of Medicine Renji Hospital, Shanghai, China.
3
Shanghai Jiao Tong University School of Medicine Ruijin Hospital, Shanghai, China zhaorensurgeon@aliyun.com.
PMID:
37342934
DOI:
10.1056/NEJMc2305030
No abstract available
Publication types
Letter
Comment
MeSH terms
COVID-19 Drug Treatment
COVID-19*
Humans
Ritonavir* / therapeutic use
Substances
nirmatrelvir
Ritonavir
GS-621763